Takeda Pharmaceuticals U.S.A., Inc.

États‑Unis d’Amérique


 
Quantité totale PI 190
Quantité totale incluant filiales 196 (+ 6 pour les filiales)
Rang # Quantité totale PI 6 852
Note d'activité PI 2,6/5.0    50
Rang # Activité PI 14 723
Parent Takeda Pharmaceutical Company Limited
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

49 43
8 33
9 15
33
 
Dernier brevet 2024 - Methods for the treatment of nuc...
Premier brevet 2002 - Enhancement of oral bioavailabil...
Dernière marque 2025 - MIMRAYO
Première marque 1990 - PREVACID

Filiales

3 subsidiaries with IP (6 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 P/S Préparations pharmaceutiques.
P/S Pharmaceutical preparations.
P/S Computer software applications, downloadable. Medical services.
2024 P/S Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders
P/S Healthcare provider and medical professional support program providing disease awareness and dise...
2023 Invention Use of maribavir in treatment regimens. Characterization of drug-drug interaction properties and...
Invention Aminothiazole compounds as c-kit inhibitors. The invention relates to c-Kit inhibitors useful in...
Invention Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-...
2022 P/S Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders Medical resea...
P/S Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders. Medical res...
Invention Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with msh3 ...
Invention Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activity....
P/S Pharmaceuticals; pharmaceuticals for use in the treatment of cancer and blood diseases and disord...
2021 Invention Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitors. This invention re...
Invention Aminothiazole compounds as c-kit inhibitors. The invention relates to c-Kit inhibitors useful in ...
P/S Pharmaceutical patient assistance program providing financial assistance for impoverished people ...
2020 P/S Pharmaceutical preparations for use in oncology.
P/S Pharmaceutical preparations for use in oncology
P/S Préparations pharmaceutiques à utiliser en oncologie, nommément préparations pharmaceutiques pour...
P/S Pharmaceutical preparations used in oncology.
P/S Pharmaceutical patient support programs providing inflammatory bowel patients, patient caregivers...
2019 Invention Methods for the treatment of trinucleotide repeat exapnsion disorders associated with ogg1 activi...
Invention Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh3 activi...
Invention Methods for the treatment of trinucleotide repeat expansion disorders associated with msh3 activi...
Invention Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh1 activi...
P/S Providing medical information to patients relating to the management of malignancies and cancer; ...
2018 Invention Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-...
P/S Pharmaceutical preparations for use in oncology
2017 Invention Aminothiazole compounds as c-kit inhibitors. 3, and n are described herein.
Invention Methods of treatment and compositions with xanthine oxidase inhibitors. Methods and pharmaceutic...
Invention Anilinopyrimidines as haematopoietic progenitor kinase 1 (hpk1) inhibitors. 4, m, and n are descr...
P/S Pharmaceutical preparations for the treatment of constipation
Invention Inducible binding proteins and methods of use. Provided herein are conditionally activated polyp...
P/S Pharmaceutical preparations for human use, namely, for the treatment of hematological malignanci...
P/S Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancie...
P/S Pharmaceutical preparations for the treatment of disorders of the central nervous system.
P/S Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
P/S Therapeutic and pharmaceutical preparations for use in the treatment of cancer, autoimmune disord...
P/S Hosting an interactive website featuring technology allowing users to construct a representation...
2016 Invention Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1...
P/S Maintaining a registry of patient data and medical information, in the field of anaplastic lympho...
P/S Pharmaceutical preparations for the treatment of gastrointestinal disorders, diseases involving v...
P/S Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for t...
P/S Pharmaceutical preparations for use in oncology.
Invention Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors...
Invention Method for treating schizophrenia comprising administering lurasidone. Disclosed herein are metho...
2015 P/S Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders
P/S Drug delivery apparatus, namely, injection instruments without needles for the delivery of pharma...
P/S Medical and surgical apparatus and instruments; drug delivery apparatus; medical fluid injectors ...
Invention Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel ...
Invention Multiple ppi dosage form. Herein provided are dosage forms (variously referred to as “formulation...
2014 Invention Pharmaceutical compositions and methods for treating age-related macular degeneration with melato...
Invention Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors. This invention relates to...
Invention Methods of treatment and compositions with xanthine oxidase inhibitors. Methods and pharmaceutica...
Invention Methods for treating hypertension. The present invention relates to methods of treating subjects...
2013 Invention Methods for administration of colchicine with grapefruit juice. Methods for safe administration ...
Invention Crystalline form c of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1...
Invention Colchicine formulations; methods of making; and methods of use thereof. Disclosed are new photos...
Invention Colchicine formulations; methods of making; and methods of use thereof. Disclosed are new photost...
Invention Substituted acetylenic imidazo[1,2-a]pyridazines as kinase inhibitors. This invention relates to ...
Invention Substituted acetylenic imidazo[1,2-a]pyrazine compounds as kinase inhibitors. This invention rela...
Invention Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors....
2012 Invention Methods for treating hypertension in black patients. The present invention relates to methods of...
Invention Combinations of azilsartan and chlorthalidone for treating hypertension black patients. The prese...